The Application segmentation of the Soft Hydrophilic Contact Lenses market is organized into vision‑correction, therapeutic, and cosmetic uses, a structure that underpins the Soft Hydrophilic Contact Lenses segmentation framework. Vision‑correction lenses, designed for myopia, hyperopia, astigmativity and presbyopia, capture the bulk of market volume—estimated at 70 %—driven by the global prevalence of refractive errors and the shift toward non‑surgical correction. Therapeutic lenses, comprising orthokeratology and drug‑delivery platforms for conditions such as keratoconus or dry‑eye syndrome, contribute roughly 20 % of revenue; their higher unit price reflects advanced material engineering and clinical validation costs. Cosmetic lenses, used primarily for aesthetic enhancement, account for the remaining 10 % and are characterized by niche demand and stricter regulatory pathways. By allocating revenue across these application segments, analysts can quantify each category’s impact on total market size and forecast differential growth patterns.